Study S001201

A Phase 1, Randomized, Cross-over, Two-period Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382 in Healthy Adult Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03341013
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2017-11-30
Primary completion: 2018-01-29
Lead sponsor: MedImmune LLC
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:MEDI0382 Formulation 2; DRUG:MEDI0382 Formulation 3
Results posted: FALSE

Registered primary outcomes

Area under the drug concentration curve [48 hours]
Maximum observed plasma concentration of MEDI0382 [48 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.